A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present new data from its prostate cancer portfolio at the upcoming American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking ...

– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...

Prostate cancer is still associated with fear and social stigma, despite being the second most common cancer among men and one that needs attention. A urologist explained that advances in treatment ...

Former U.S. President Joe Biden’s recent cancer diagnosis brought widespread attention to what is known as the “Gleason score,” a grading system used to assess the prognosis of men with prostate ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

The myth is that prostate cancer treatment destroys men’s erections. The truth is more complicated. Men facing treatment for this disease should prepare themselves emotionally for permanent erectile ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...

Scott Adams previously asked President Donald Trump to intervene with his insurer over delayed cancer treatment ...